Drw Securities, LLC Leap Therapeutics, Inc. Transaction History

Drw Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.39 - $3.07 $70,214 - $155,077	-50,514 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $7.94 $3,866 - $15,991	2,014 Added 4.15%	50,514 $101,000
Q3 2018 Nov 14, 2018	BUY	$6.52 - $9.13 $65,199 - $91,300	10,000 Added 25.97%	48,500 $378,000
Q2 2018 Aug 14, 2018	BUY	$6.76 - $10.01 $260,260 - $385,385	38,500 New	38,500 $347,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $199M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.